DMTC is pleased to announce the signing of a Memorandum of Understanding between Health Security Systems Australia (HSSA), a division of DMTC, and Biointelect Pty Ltd.
The partnership will boost Australia’s resilience and preparedness for current and emerging health threats through enhanced cooperation and coordination. It will explore opportunities to support infectious disease innovations with local and global health security impact, and technologies with dual civilian and military applications. Clearer, more efficient product pathways - from research and development to commercialisation and end-user adoption - will be a key focus.
Australia’s ability to anticipate, detect and respond rapidly to these threats hinges on ensuring research, industry, government and end-user capabilities are connected and ready to turn innovation into practical solutions.
Harry Baxter, Head of HSSA, said the agreement allows both organisations to explore how best to combine their complementary capabilities to support and strengthen Australia’s national health security.
"Global health security is an urgent challenge, and two recent severe bacterial outbreaks in Northern Australia show we cannot be complacent. Australia's ability to respond requires collaboration across government, research, industry and the broader innovation ecosystem. This agreement enables HSSA and Biointelect to explore opportunities to combine our capabilities for national benefit."
"We are particularly excited about the opportunity to strengthen pathways between research, capability development, commercialisation and end-user needs, helping ensure promising Australian innovations have the greatest possible opportunity to create real-world impact."
About Biointelect Venturer
Biointelect Venturer is Australia’s national incubator for infectious disease innovation, helping promising Australian scientific innovators accelerate their path from discovery to impact. Funded by the Australian Government's Medical Research Future Fund (MRFF) through the 2024 BioMedTech Incubator grant opportunity, Biointelect Venturer combines catalytic non-dilutive funding with commercialisation expertise, strategic guidance, networks and tailored support to progress early-stage innovations towards commercial and investment readiness. Managed and operated by Biointelect, the incubator builds on Biointelect’s deep expertise and success in supporting early-stage biotech and medtech commercialisation.
About Health Security Systems Australia (HSSA)
Health Security Systems Australia, a division of DMTC Limited, leads collaborative capability uplift and research and development initiatives designed to mitigate threats posed by chemical, biological, radiological and nuclear hazards, including infectious diseases and pandemics, for both Defence and civilian populations. HSSA works with partners across government, industry, academia and Defence to strengthen Australia's health security capabilities and resilience.
